Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06779214
NA

Effect of Food-derived Active Components on Digestive Tract Health in Adults with Irritable Bowel Syndrome

Sponsor: Peking University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if Bifidobacterium. animalis subsp. Lactis A6 Strain or resveratrol to improve the symptoms of diarrhea-predominate irritable bowel syndromes (IBS-D). The main questions it aims to answer are: 1. Does Bifidobacterium animalis subsp.Lactis A6 Strain or resveratrol improve the symptoms of IBS-D. 2. What is the optimal intervention dose of Bifidobacterium. animalis subsp.Lactis A6 Strain or resveratrol to improve IBS-D Researchers will compare Bifidobacterium. animalis subsp.Lactis A6 Strain or resveratrol interventions to placebo (one look-alike sunbstance that contains no interventions substance) to see if Bifidobacterium. animalis subsp.Lactis A6 Strain or resveratrol relief the symptoms of patients with IBS-D. Participants will: 1. Take Bifidobacterium. animalis subsp.Lactis A6 Strain or resveratrol every day for 30 days. 2. Visit the clinic once every 15 days for checkups and tests.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2025-02-28

Completion Date

2025-12-31

Last Updated

2025-01-16

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Prebiotic_L

subject will receive a low-dosage (1\*10\^5) of Bifidobacterium. animalis subsp.Lactis A6 Strain

DIETARY_SUPPLEMENT

resveratrol_L

subject will receive a low-dosage (300mg/d) of resveratrol

DIETARY_SUPPLEMENT

Prebiotic_M

subject will receive a medium-dosage (1\*10\^8) of Bifidobacterium. animalis subsp.Lactis A6 Strain

DIETARY_SUPPLEMENT

Prebiotic_H

subjects will receive a high-dosage (1\*10\^10) of Bifidobacterium. animalis subsp.Lactis A6 Strain

DIETARY_SUPPLEMENT

resveratrol_H

subject will receive a low-dosage (600mg/d) of resveratrol

OTHER

placebo_Bif

subjects will receive placebo (one look-alike sunbstance that contains no prebiotics)

OTHER

placebo_resveratrol

subjects will receive placebo (one look-alike sunbstance that contains no resveratrol)

Locations (1)

Peking University

Beijing, Beijing Municipality, China